Learn About Spinocerebellar Ataxia Type 7

What is the definition of Spinocerebellar Ataxia Type 7?
Spinocerebellar ataxia 7 (SCA7) is an inherited disease of the central nervous system that leads to impairment of specific nerve fibers carrying messages to and from the brain, resulting in degeneration of the cerebellum (the coordination center of the brain). SCA7 differs from most other forms of SCA in that visual problems, rather than poor coordination, are generally the earliest signs of the disease. Affected individuals have progressive changes in vision (which can result in blindness); symptoms of ataxia; slow eye movements; and mild changes in sensation or reflexes. Later symptoms include loss of motor control, unclear speech (dysarthria), and difficulty swallowing (dysphagia). SCA7 is caused by genetic changes in the ATXN7 gene and is inherited in an autosomal dominant manner.
Save information for later
Sign Up
What are the alternative names for Spinocerebellar Ataxia Type 7?
  • Spinocerebellar ataxia 7
  • ADCA, TYPE II
  • Autosomal dominant cerebellar ataxia type 2
  • OPCA III
  • OPCA with macular degeneration and external ophthalmoplegia
  • OPCA with retinal degeneration
  • OPCA3
  • Olivopontocerebellar atrophy 3
  • SCA7
  • Spinocerebellar ataxia type 7
Who are the top Spinocerebellar Ataxia Type 7 Local Doctors?
Elite
Elite
 
 
 
 
Learn about our expert tiers
Learn more
Elite
What are the latest Spinocerebellar Ataxia Type 7 Clinical Trials?
Neuropsychiatry and Cognition in the Context of Spinocerebellar Ataxia Type 3/Machado-Joseph Disease (SCA3/MJD)
Summary: This research investigates how cognitive-affective aspects evolve during the course of SCA3/MJD. Due to COVID-19 pandemics, this study protocol was adapted for online-only consultations. Evaluations happening after March 2020 have been done by videocall with patients, and no neurological evaluation was thus performed on these patients. A scale on Activities of Daily Living was added to the online ...
Match to trials
Find the right clinical trials for you in under a minute
Get started
A Clinical Research on the Safety/Efficacy of Umbilical Cord Mesenchymal Stem Cells Therapy for Patients With Spinocerebellar Ataxia
Summary: The purpose of this study is verify the safety and efficacy of Human Umbilical Cord Mesenchymal Stem Cells (UC-MSC) therapy for patients with Spinocerebellar Ataxia, and in addition, explore the possible mechanisms of UC-MSC therapy in Spinocerebellar Ataxia.
Who are the sources who wrote this article ?

Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center

What are the Latest Advances for Spinocerebellar Ataxia Type 7?
Safety and efficacy of riluzole in spinocerebellar ataxia type 2 in France (ATRIL): a multicentre, randomised, double-blind, placebo-controlled trial.
Summary: Safety and efficacy of riluzole in spinocerebellar ataxia type 2 in France (ATRIL): a multicentre, randomised, double-blind, placebo-controlled trial.
Effectiveness of Robotic Exoskeleton-Assisted Gait Training in Spinocerebellar Ataxia: A Case Report.
Summary: Effectiveness of Robotic Exoskeleton-Assisted Gait Training in Spinocerebellar Ataxia: A Case Report.
Tired of the same old research?
Check Latest Advances
Ophthalmic Features of Spinocerebellar Ataxia Type 7: A Case Report.
Summary: Ophthalmic Features of Spinocerebellar Ataxia Type 7: A Case Report.